AU584468B2 - Pharmaceutical composition having a synergistic anti- inflammatory activity based on a combination of a corticosteroid and a `` agonist - Google Patents

Pharmaceutical composition having a synergistic anti- inflammatory activity based on a combination of a corticosteroid and a `` agonist

Info

Publication number
AU584468B2
AU584468B2 AU64124/86A AU6412486A AU584468B2 AU 584468 B2 AU584468 B2 AU 584468B2 AU 64124/86 A AU64124/86 A AU 64124/86A AU 6412486 A AU6412486 A AU 6412486A AU 584468 B2 AU584468 B2 AU 584468B2
Authority
AU
Australia
Prior art keywords
corticosteroid
agonist
combination
pharmaceutical composition
inflammatory activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU64124/86A
Other versions
AU6412486A (en
Inventor
Christopher Hensby
Braham Shroot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre International de Recherches Dermatologiques Galderma filed Critical Centre International de Recherches Dermatologiques Galderma
Publication of AU6412486A publication Critical patent/AU6412486A/en
Application granted granted Critical
Publication of AU584468B2 publication Critical patent/AU584468B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AU64124/86A 1985-10-16 1986-10-15 Pharmaceutical composition having a synergistic anti- inflammatory activity based on a combination of a corticosteroid and a `` agonist Ceased AU584468B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8515355A FR2588474B1 (en) 1985-10-16 1985-10-16 SYNERGETIC ANTI-INFLAMMATORY COMPOSITIONS BASED ON A CORTICOSTEROID AND AN AGONIST BETA
FR8515355 1985-10-16

Publications (2)

Publication Number Publication Date
AU6412486A AU6412486A (en) 1987-04-30
AU584468B2 true AU584468B2 (en) 1989-05-25

Family

ID=9323889

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64124/86A Ceased AU584468B2 (en) 1985-10-16 1986-10-15 Pharmaceutical composition having a synergistic anti- inflammatory activity based on a combination of a corticosteroid and a `` agonist

Country Status (10)

Country Link
EP (1) EP0223671B1 (en)
JP (1) JPS62116515A (en)
AU (1) AU584468B2 (en)
CA (1) CA1289884C (en)
DE (2) DE223671T1 (en)
DK (1) DK172800B1 (en)
FR (1) FR2588474B1 (en)
IL (1) IL80308A (en)
NZ (1) NZ217939A (en)
ZA (1) ZA867822B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028431A (en) * 1987-10-29 1991-07-02 Hercon Laboratories Corporation Article for the delivery to animal tissue of a pharmacologically active agent
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Pharmaceutical compositions comprising salmeterol and fluticasone propionate
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
DK0416950T3 (en) * 1989-09-08 1993-10-11 Glaxo Group Ltd medications
WO2001019373A2 (en) * 1999-09-17 2001-03-22 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
BRPI0212455B8 (en) 2001-09-14 2021-05-25 Glaxo Group Ltd compound derived from phenethanolamine for the treatment of respiratory diseases, pharmaceutical formulation, combination, and use thereof
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107715A (en) * 1981-10-19 1983-05-05 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107715A (en) * 1981-10-19 1983-05-05 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it

Also Published As

Publication number Publication date
NZ217939A (en) 1990-02-26
DK492486A (en) 1987-04-17
DK172800B1 (en) 1999-07-26
ZA867822B (en) 1987-06-24
EP0223671B1 (en) 1991-11-27
FR2588474B1 (en) 1987-11-27
IL80308A (en) 1991-03-10
JPS62116515A (en) 1987-05-28
CA1289884C (en) 1991-10-01
DK492486D0 (en) 1986-10-15
AU6412486A (en) 1987-04-30
FR2588474A1 (en) 1987-04-17
EP0223671A1 (en) 1987-05-27
IL80308A0 (en) 1987-01-30
DE3682656D1 (en) 1992-01-09
DE223671T1 (en) 1987-11-05

Similar Documents

Publication Publication Date Title
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
EP0249561A3 (en) Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
AU5016585A (en) Dipeptide compounds having pharmaceutical activity and compositions containing them
IL77758A (en) Dihydro and tetrahydro-quinoline and naphthalene derivatives and pharmaceutical compositions containing the same
AU7554087A (en) Pharmaceutical composition with analgesic activity
AU588365B2 (en) Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
AU585739B2 (en) Anti-inflammatory and analgesic tape for external use
NZ217597A (en) Urea derivatives and pharmaceutical compositions
ZA869014B (en) Benzoic acid and benzoic acid derivatives having anti-inflammatory and analgesic activity
AU1795383A (en) Pharmaceutical preparations having analgetic and cytostatic activity
AU578992B2 (en) Polyester-polyurethane composition and use thereof
NZ211905A (en) Phenol derivatives having antioestrogenic activity and pharmaceutical compositions
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
AU1846488A (en) Analgesic and anti-inflammatory thiourea derivatives
AU584468B2 (en) Pharmaceutical composition having a synergistic anti- inflammatory activity based on a combination of a corticosteroid and a `` agonist
AU7543887A (en) Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ216894A (en) Penicillin derivatives and pharmaceutical compositions
NZ215753A (en) Phenethanolamine derivatives and pharmaceutical compositions
NZ218237A (en) Oxazolone derivatives and pharmaceutical compositions
NZ217871A (en) Oxazole derivatives and pharmaceutical compositions
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
AU570582B2 (en) Pharmaceutical composition of flupirtine and 4-acetamidophenol
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired